Cargando…

Hypermethylation Leads to Bone Morphogenetic Protein 6 Downregulation in Hepatocellular Carcinoma

BACKGROUND: In the liver, bone morphogenetic protein 6 (BMP-6) maintains balanced iron metabolism. However, the mechanism that underlies greater BMP-6 expression in hepatocellular carcinoma (HCC) tissue than adjacent non-cancerous tissue is unclear. This study sought to investigate the epigenetic me...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yinghua, Cui, Ying, Xu, Baiying, Gu, Jun, Wang, Wei, Luo, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907571/ https://www.ncbi.nlm.nih.gov/pubmed/24498236 http://dx.doi.org/10.1371/journal.pone.0087994

Ejemplares similares

SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
por: Acun, Tolga, et al.
Publicado: (2011)

Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
por: Chen, Mingquan, et al.
Publicado: (2011)

Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism
por: Zhong, Xuemin, et al.
Publicado: (2022)

Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma
por: Nawaz, Imran, et al.
Publicado: (2015)

The detrimental effects of glucocorticoids exposure during pregnancy on offspring’s cardiac functions mediated by hypermethylation of bone morphogenetic protein-4
por: Peng, Jieying, et al.
Publicado: (2018)

Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro
por: Kersten, Vanessa, et al.
Publicado: (2023)

Quantitative analysis of APC promoter methylation in hepatocellular carcinoma and its prognostic implications
por: XU, BAIYING, et al.
Publicado: (2014)

Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma
por: Huang, Chuang, et al.
Publicado: (2016)

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
por: Nomoto, S, et al.
Publicado: (2007)

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
por: Fu, Siyu, et al.
Publicado: (2023)

Hypermethylation downregulates P2X(7) receptor expression in astrocytoma
por: Liu, Jing, et al.
Publicado: (2017)

Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins
por: Luo, Wen-Li, et al.
Publicado: (2020)

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008)

The Classic: Bone Morphogenetic Protein
por: Urist, Marshall R., et al.
Publicado: (2009)

Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma
por: Zhou, Jin, et al.
Publicado: (2018)

The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Changsong, et al.
Publicado: (2012)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration
por: Wu, Minhua, et al.
Publicado: (2021)

Bone morphogenetic protein-4 and bone morphogenetic protein receptors expressions in the adult rat eye
por: Maruyama-Koide, Yuka, et al.
Publicado: (2017)

Hypermethylation of SCAND3 and Myo1g Gene Are Potential Diagnostic Biomarkers for Hepatocellular Carcinoma
por: Xu, Fei, et al.
Publicado: (2020)

Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation
por: LIN, JIAYING, et al.
Publicado: (2014)

Hypermethylation of mitochondrial DNA facilitates bone metastasis of renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2022)

A novel role of bone morphogenetic protein 6 (BMP6) in glucose homeostasis
por: Pauk, Martina, et al.
Publicado: (2018)

Promoter hypermethylation and downregulation of trefoil factor 2 in human gastric cancer
por: JIANG, PING, et al.
Publicado: (2014)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features
por: Xing, Xiangling, et al.
Publicado: (2022)

Tumor necrosis factor alpha downregulates bone morphogenetic protein expression and matrix macromolecule synthesis in articular cartilage
por: Bobacz, K, et al.
Publicado: (2004)

Bone Morphogenetic Protein 6 Inhibits the Immunomodulatory Property of BMMSCs via Id1 in Sjögren's Syndrome
por: Su, Yingying, et al.
Publicado: (2018)

Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2016)

Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer
por: Qin, Jun, et al.
Publicado: (2015)

Insights into bone morphogenetic proteins in cardiovascular diseases
por: Ye, Di, et al.
Publicado: (2023)

Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide
por: CUI, LIMING, et al.
Publicado: (2016)

Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population
por: Jung, Jae Woo, et al.
Publicado: (2016)

Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study
por: Ding, Xianglian, et al.
Publicado: (2016)

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017)

DNA hypermethylation of aurora kinase A in hepatitis C virus-positive hepatocellular carcinoma
por: Ma, Zuohong, et al.
Publicado: (2019)

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma
por: Mansour, Lamiaa A, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019)

Bioactive Polyetheretherketone with Gelatin Hydrogel Leads to Sustained Release of Bone Morphogenetic Protein-2 and Promotes Osteogenic Differentiation
por: Zhang, Ruonan, et al.
Publicado: (2023)

Bone Morphogenetic Protein‐6 Attenuates Type 1 Diabetes Mellitus‐Associated Bone Loss
por: Wang, Jesse F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibcgubbj8utlj3t51bulm9p7ev